Vanguard Group Inc Glaukos Corp Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Glaukos Corp stock. As of the latest transaction made, Vanguard Group Inc holds 6,112,219 shares of GKOS stock, worth $546 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,112,219
Previous 5,965,115
2.47%
Holding current value
$546 Million
Previous $587 Million
7.54%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding GKOS
# of Institutions
334Shares Held
54.1MCall Options Held
260KPut Options Held
484K-
Black Rock Inc. New York, NY8.04MShares$718 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$290 Million0.06% of portfolio
-
State Street Corp Boston, MA2.09MShares$187 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2MShares$179 Million0.05% of portfolio
-
Primecap Management CO Pasadena, CA1.83MShares$163 Million0.15% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.25B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...